-
Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer ETHealthWorld
-
West Pharma posts beat-and-raise quarter aided by strong demand for injectables ETHealthWorld
-
Biopharma Layoff Tracker 2024: BMS, CureVac, Tessera and More Cut Staff BioSpace
-
National Capacity Variance/Generator Status: U.S. Environmental Protection Agency Guidance Addresses Hazardous ... JD Supra
-
Bypassing Safeguards: The Issue of Substandard Drugs in the US and EU MedicalResearch.com
-
Medical devices companies to soon have 'unique' pricing model The Economic Times
-
Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines MedCity News
-
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key ... Yahoo Finance
-
Inflation Reduction Act to have knock on effect on R&D, say biotech experts Pharmaceutical Technology
-
AstraZeneca CEO says platform deals largely done after M&As in vaccines, radioligand, cell therapy FiercePharma